Feasibility and limitations of comorbidity measurement in patients undergoing radical prostatectomy

European Urology

Volumn 47, Issue 2, 2005, Pages 190-195

  Froehner, Michael ^a   Koch, Rainer ^a   Litz, Rainer J ^a   Oehlschlaeger, Sven ^a   Hakenberg, Oliver W ^a   Wirth, Manfred P ^a  

^a UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

Author keywords

Age; ASA classification; Charlson score; Comorbidity; Heart disease; Preoperative cardiopulmonary risk assessment; Prognostic factors; Prostate cancer; Radical prostatectomy; Survival

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ANGINA PECTORIS; CARDIOVASCULAR RISK; CHRONIC LUNG DISEASE; COMORBIDITY; CONFERENCE PAPER; CONTROLLED STUDY; DATA ANALYSIS; DIABETES MELLITUS; DISEASE CLASSIFICATION; FOLLOW UP; HEART FAILURE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL DECISION MAKING; MORTALITY; PERIPHERAL VASCULAR DISEASE; PREDICTION; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; RISK ASSESSMENT; SCORING SYSTEM; STATISTICAL SIGNIFICANCE; SURVIVAL RATE; TREATMENT OUTCOME;

AGED; COMORBIDITY; FEASIBILITY STUDIES; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS; SURVIVAL ANALYSIS;

EID: 12344267754     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eururo.2004.07.031     Document Type: Article

References (19)

1. A.W. Partin, M.W. Kattan, E.N. Subong, P.C. Walsh, K.J. Wojno, and J.E. Oesterling Combination of prostate-specific antigen, clinical stage and Gleason score to predict pathologic stage of localized prostate cancer. A multi-institutional update JAMA 277 1997 1445 1451
2. M.W. Kattan, T.M. Wheeler, and P.T. Scardino Postoperative nomogram for disease recurrence after radical prostatectomy for prostate cancer J Clin Oncol. 17 1999 1499 1507
3. R.J. Palisaar, M. Graefen, P.I. Karakiewicz, P.G. Hammerer, E. Huland, and A. Haese Assessment of clinical and pathologic characteristics predisposing to disease recurrence following radical prostatectomy in men with pathologically organ-confined prostate cancer Eur Urol. 41 2002 155 161
4. M. Han, A.W. Partin, M. Zahurak, S. Piantadosi, J.I. Epstein, and P.C. Walsh Biochemical (prostate specific antigen) recurrence probability following radical prostatectomy for clinically localized prostate cancer J Urol. 169 2003 517 523
5. N. Rosenblum, and H. Lepor Radical retropubic prostatectomy. Preoperative management Urol Clin North Am. 28 2001 499 507
6. J. Noldus, and H. Huland Die operative Therapie des Prostatakarzinoms Onkologie 26 2003 6 12
7. P.C. Albertsen, D.G. Fryback, B.E. Storer, T.F. Kolon, and J. Fine The impact of co-morbidity on life expectancy among men with localized prostate cancer J Urol. 156 1996 127 132
8. M.J. Barry, P.C. Albertsen, M.A. Bagshaw, M.L. Blute, R. Cox, and R.G. Middleton Outcomes for men with clinically nonmetastatic prostate carcinoma managed with radical prostatectomy, external beam radiotherapy, or expectant management: a retrospective analysis Cancer 91 2001 2302 2314
9. M. Froehner, R. Koch, R. Litz, A. Heller, S. Oehlschlaeger, and M.P. Wirth Comparison of the American Society of Anesthesiologists Physical Status classification with the Charlson score as predictors of survival after radical prostatectomy Urology 62 2003 698 701
10. M. Froehner, R. Koch, R. Litz, S. Oehlschlaeger, B. Noack, and A. Manseck Preoperative cardiopulmonary risk assessment as predictor of early non-cancer and overall mortality after radical prostatectomy Urology. 61 2003 596 600
11. M. Froehner, R. Koch, R. Litz, S. Oehlschlaeger, and M.P. Wirth Which conditions contributing to the Charlson score predict survival after radical prostatectomy? J Urol. 171 2004 697 699
12. L. Holmberg, A. Bill-Axelson, F. Helgesen, J.O. Salo, P. Folmerz, and M. Häggman A randomized trial comparing radical prostatectomy with watchful waiting in early prostate cancer N Engl J Med. 347 2002 781 789
13. M.E. Charlson, P. Pompei, K.L. Ales, and C.R. MacKenzie A new method of classifying prognostic comorbidity in longitudinal studies: development and validation J Chron Dis. 40 1987 373 383
14. W.D. Owens, J.A. Felts, and E.J.L. Spitznagel ASA physical status classifications: a study of consistency of ratings Anesthesiology 49 1978 239 243
15. W.J. Catalona, G.R. Ramos, and G.F. Carvalhal Contemporary results of anatomic radical prostatectomy CA Cancer J Clin. 49 1999 282 286
16. P.N. Post, B.E. Hansen, P.J.M. Kil, M.L.G. Janssen-Heijnen, and J.W.W. Coebergh The independent prognostic value of comorbidity among men aged <75 years with localized prostate cancer: a population-based study BJU Int. 87 2001 821 826
17. L. Eapen, P.J. Villeneuve, I.G. Levy, and H.I. Morrison Comorbid survival among elderly participants of the Canada Health Survey: Relevance to prostate cancer screening and treatment Chronic Dis Can. 19 1998 84 90
18. M.E. Allaf, and H.B. Carter Update on watchful waiting for prostate cancer Curr Opin Urol. 14 2004 171 174
19. C.A. Carter, T. Donohue, L. Sun, H. Wu, D.G. McLeod, and C. Amling Temporarily deferred therapy (watchful waiting) for men younger than 70 years and with low-risk localized prostate cancer in the prostate-specific antigen era J Clin Oncol. 21 2003 4001 4008